The White House losing a key tariff court case at the Court of International Trade isn’t the end of the story with respect to ...

In recent trading, shares of Goldman Sachs BDC Inc (Symbol: GSBD) have crossed above the average analyst 12-month target price of $11.07, changing hands for $11.25/share. When a stock reaches the ...

Goldman Sachs initiated coverage on Insulet Corporation (NASDAQ:PODD)’s stock, assigning a “Buy” rating with the price ...

On May 30, a Goldman Sachs analyst reiterated a bullish stance on Alphabet Inc. (NASDAQ:GOOGL), maintaining a Buy rating and ...

Brian Lee – upgraded First Solar, Inc. (NASDAQ:FSLR) price target from $204 to $255, keeping a ‘Buy’ rating on the stock.

A High Flying Nasdaq 100 ETF, a double digit yielding dividend and the Goldman Sachs market savvy behind it - Sounds like a ...

Goldman Sachs revised its outlook for Hesai Group (NASDAQ:HSAI) on May 27, reiterating its Buy rating and increasing the ...

Q3 FY 2025 earnings results, a Goldman Sachs analyst reiterated a Buy rating on the stock and slightly raised the price ...

On May 27, Goldman Sachs raised the firm’s price target on Hesai Group (NASDAQ: HSAI) from $20.4 to $23.3, while keeping a ...

Investing.com -- Goldman Sachs has initiated coverage of diabetes technology stocks Insulet (NASDAQ: PODD) and Dexcom (NASDAQ: DXCM) with Buy ratings, citing strong long-term growth prospects in both ...

US stocks moved higher on Thursday as markets assessed Nvidia's earnings report as well as more tariff uncertainty.